DJIA 16,943.81 28.74 0.17%
NASDAQ 4,415.49 19.29 0.44%
S&P 500 1,967.57 2.89 0.15%
market minute promo

InterMune (NASDAQ: ITMN)

42.83 1.18 (2.83%)

REAL-TIME: Last trade at

Extended Hours: $42.83 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ITMN $42.83 2.83%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $41.19
Previous Close $41.65
Daily Range $40.96 - $43.02
52-Week Range $10.65 - $47.65
Market Cap $4.2B
P/E Ratio -15.78
Dividend (Yield) $0.00 (0.0%)
Volume 959,482
Average Daily Volume 1,759,244
Current FY EPS -$2.31

Sector

Healthcare

Industry

Drugs

InterMune (ITMN) Description

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. Website: http://www.intermune.com/

News & Commentary Rss Feed

InterMune Inc. ASCENDs to Greatness

InterMune succeeds where Gilead and Novartis failed. Its IPF drug Esbriet looks destined for approval.

Use Options For a Chance To Buy InterMune at a 42% Discount

4 Biotech Stocks Worth A Look Ahead Of FDA Approvals

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

3 Hot Biotech Stocks Hitting Highs

Today In SA PRO: Friday, June 13

InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed F

InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed For

JMP Continues To Recommend Intermune At Current Levels

IWM, PTC, AZPN, ITMN: Large Inflows Detected at ETF

Insider Trading Alert - ROSE, ITMN And MHFI Traded By Insiders

After Idenix: The Next Four Biotech Buyout Candidates

See More ITMN News...

ITMN's Top Competitors

ITMN $42.83 (2.83%)
Current stock: ITMN
AMGN $119.77 (0.69%)
Current stock: AMGN
GILD $88.73 (-0.24%)
Current stock: GILD
BIIB $322.22 (0.97%)
Current stock: BIIB